Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03146936

Swiss Primary Sclerosing Cholangitis Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Fondazione Epatocentro Ticino · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.

Detailed description

The investigators wish to collect high quality prospective data on a rare disease in order to elucidate epidemiology, natural history, response to treatment and outcome. In addition, a biobank allows addressing specific scientific issues on a variety of open questions. The cohort will provide a platform for carrying out scientific research projects on PSC. In addition, the cohort will allow collaborations with reference networks on PSC abroad

Conditions

Timeline

Start date
2017-02-28
Primary completion
2030-12-31
Completion
2030-12-31
First posted
2017-05-10
Last updated
2025-08-19

Locations

21 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03146936. Inclusion in this directory is not an endorsement.

Swiss Primary Sclerosing Cholangitis Cohort Study (NCT03146936) · Clinical Trials Directory